Today: 21 May 2026
Rheinmetall stock jumps 7% on Bundeswehr ammo order as Venezuela headlines lift defence shares
5 January 2026
1 min read

Rheinmetall stock jumps 7% on Bundeswehr ammo order as Venezuela headlines lift defence shares

FRANKFURT, Jan 5, 2026, 05:36 ET — Premarket

Rheinmetall AG shares (RHMG.DE) were up about 7% in early Frankfurt trading on Monday, with the stock last indicated around 1,712 euros. That followed a Friday close near 1,602 euros.

The move tracked a sharp bid for European defence names after U.S. military action in Venezuela over the weekend, which pushed the sector index to its highest since late October. Jefferies analysts said the Venezuela strike could shift Washington’s focus to other geopolitical flashpoints and keep pressure on governments to raise defence budgets faster.

Rheinmetall also flagged fresh domestic demand. The company said Germany’s Bundeswehr extended a 2022 framework contract — an umbrella deal that allows “call-off” orders over time — for 30mm ammunition for the Puma infantry fighting vehicle, with a new order worth several hundred million euros. It said the expanded framework runs until 2029 and provides for delivery of several hundred thousand cartridges worth around 1 billion euros. Rheinmetall

The rally comes after a volatile stretch for Europe’s defence complex, where share prices have swung with each shift in the geopolitical narrative. Rheinmetall is closely watched because its ammunition and vehicle businesses tend to move quickly with procurement headlines, unlike longer-cycle platforms such as jets or ships.

In the wider market, European stocks hit a record high on Monday, with Rheinmetall among the top drivers in Germany’s DAX.

“Given the unexpected turn of events in Venezuela over the weekend, it remains to be seen whether the Trump administration has an appetite for more regime changes,” said Vasu Menon at OCBC in Singapore. Reuters

Technically, momentum indicators look stretched after the jump. Rheinmetall’s 14-day relative strength index (RSI) — a momentum gauge that traders use to spot overheated moves — was above 80, a level often associated with “overbought” conditions after fast gains. Investing

Investors will be watching for follow-through after the initial spike, and whether the latest Bundeswehr call-off points to larger, repeat procurement orders as Germany seeks to rebuild ammunition stocks.

But sentiment can turn quickly. Any cooling in geopolitical tensions, or renewed speculation about a Ukraine ceasefire, could sap demand for defence stocks and trigger profit-taking, especially in names that have rallied hard on headlines.

Stock Market Today

  • EU Biotech Faces Capital Challenges Despite Strong Science, Says Euronext Brussels CEO
    May 20, 2026, 10:36 PM EDT. Belgium's biotech sector exemplifies Europe's scientific prowess but faces significant financing challenges, according to Euronext Brussels CEO Benoît van den Hove. While innovation thrives, access to capital beyond national markets remains a critical hurdle. European biotech firms require abundant funding to scale, yet the continent lacks deep, integrated financial pools, risking valuable expertise shifting abroad. The success of Belgian biotech Argenx, which combined strong science with substantial capital raised through both domestic and international investors, underscores this need. Although most European biotech companies are listed locally, the challenge is securing sufficient funding to sustain growth rather than relocation to the US.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Alien-signal hunt finds nothing from interstellar comet 3I/ATLAS after Green Bank scan
Previous Story

Alien-signal hunt finds nothing from interstellar comet 3I/ATLAS after Green Bank scan

Brand Engagement Network (BNAI) stock rises again premarket as AI pharma deal keeps traders hooked
Next Story

Brand Engagement Network (BNAI) stock rises again premarket as AI pharma deal keeps traders hooked

Go toTop